Renaissance Technologies LLC 13D/13G Filings for ARCA biopharma, Inc. (ABIO)

Renaissance Technologies LLC 13D and 13G filings for ARCA biopharma, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2021-02-10
1:45 pm
Purchase
2020-12-31 13G ARCA biopharma, Inc.
ABIO
Renaissance Technologies LLC 17,125
2.200%
5,244increase
(+44.14%)
Filing